CASI Pharmaceuticals
CASI
#9780
Rank
โ‚ฌ28.56 M
Marketcap
1,84ย โ‚ฌ
Share price
0.32%
Change (1 day)
-35.78%
Change (1 year)

Revenue for CASI Pharmaceuticals (CASI)

Revenue in 2024 (TTM): โ‚ฌ26.67 Million

According to CASI Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚ฌ26.09 Million. a decrease over the revenue in the year 2023 that were of โ‚ฌ30.64 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for CASI Pharmaceuticals from 1996 to 2024

Annual revenue

Year Revenue Change
2024 โ‚ฌ27.42 M-10.52%
2023 โ‚ฌ30.64 M-23.74%
2022 โ‚ฌ40.18 M50.86%
2021 โ‚ฌ26.63 M116.4%
2020 โ‚ฌ12.3 M233.81%
2019 โ‚ฌ3.68 M
2018 N/A
2017 N/A
2016 N/A-100%
2015 โ‚ฌ0.04 M123.67%
2014 โ‚ฌ0.01 M
2013 N/A-100%
2012 โ‚ฌ0.5 M-66.14%
2011 โ‚ฌ1.49 M-46.17%
2010 โ‚ฌ2.77 M-24.72%
2009 โ‚ฌ3.68 M
2005 โ‚ฌ4.99 M1218.46%
2004 โ‚ฌ0.37 M-69.72%
2003 โ‚ฌ1.25 M11.19%
2002 โ‚ฌ1.12 M-46.62%
2001 โ‚ฌ2.1 M-45.91%
2000 โ‚ฌ3.89 M-21.13%
1999 โ‚ฌ4.94 M12.78%
1998 โ‚ฌ4.38 M8.33%
1997 โ‚ฌ4.04 M9.09%
1996 โ‚ฌ3.7 M